Darwin Formulations Private Limited, a active private limited company, was established on 17 February 1995 in Na, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1995PTC019481. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.99 M.
It upholds a compliant status. Employing 19 professional, Its leadership includes Venkata Kripamani Donthireddy (Director), Lakshmanareddy Dontireddy (Managing Director), Prvdhvi Chandra Reddy Donthireddy (Director). Past directors included Lakshmanareddy Dontireddy, Prvdhvi Chandra Reddy Donthireddy. It holds ₹7.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 97-B,Vengalrao Nagarhyderabad, Na, Telangana.
U24239TG1995PTC019481
019481
17 February 1995
₹1.00 M
₹0.99 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Darwin Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkata Kripamani Donthireddy | Director | 21 Mar 1998 | Current |
| Lakshmanareddy Dontireddy | Managing Director | 17 Feb 1995 | Current |
| Prvdhvi Chandra Reddy Donthireddy | Director | 01 Apr 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Mar 1995 | Past |
| Pramod Abcsdd | Additional Director | 01 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Darwin Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.53% increase. The company also saw a slight improvement in profitability, with a 9.65% increase in profit. The company's net worth Soared by an impressive increase of 12.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Darwin Formulations had a public holding of 13.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹77,506,761.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2024 | Others | ₹5.00 Cr | Open |
| 27 Apr 2021 | Hdfc Bank Limited | ₹2.01 M | Open |
| 25 Feb 2014 | Kotak Mahindra Bank Limited | ₹1.75 Cr | Open |
| 18 Dec 2009 | Indian Overseas Bank | ₹2.50 M | Open |
| 20 Feb 1996 | State Bank Of India | ₹5.50 M | Open |
Explore comprehensive loan charge details -
Darwin Formulations has a workforce of 19 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Darwin Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darwin Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Darwin Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Others amounted to Rs. 50.00 M with Charge ID 100981338 was registered on 30 Aug 2024. was recorded as a recent event.
Progress on Darwin Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 2.01 M with Charge ID 100484577 was registered on 27 Apr 2021. was completed.
A charge with Kotak Mahindra Bank Limited amounted to Rs. 17.50 M with Charge ID 10493943 was registered on 25 Feb 2014. was recorded as a recent event.
Progress on Prvdhvi Chandra Reddy Donthireddy was appointed as a Director was appointed as a Director on 01 Apr 2013 & has been associated with this company since 12 years 8 months . was documented.
The CIN of Darwin Formulations Private Limited is U24239TG1995PTC019481.
Darwin Formulations Private Limited is headquartered at 97-B,Vengalrao Nagarhyderabad, Na, Telangana.
Darwin Formulations Private Limited was incorporated on 17 February 1995.
The current directors of Darwin Formulations Private Limited are
The primary industry of Darwin Formulations Private Limited is Manufacturing.
Darwin Formulations Private Limited is unlisted.
The authorized capital of Darwin Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.99 M.
The compliance status of Darwin Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX